Dexcom (DXCM) Acquisitions (2021 - 2022)
Dexcom (DXCM) reported Acquisitions of $700000.0 for Q3 2022, down 97.78% year-over-year from $31.6 million in Q3 2021, and down 78.12% quarter-over-quarter from $3.2 million in Q1 2022.
Dexcom (DXCM) Acquisitions (2021 - 2022) Analysis & Trends
Dexcom (DXCM) has 2 years of Acquisitions data on file, last reported at $700000.0 in Q3 2022.
- Acquisitions for Q3 2022 came in at $700000.0, down 97.78% year-over-year; the trailing twelve-month figure through Jun 2023 was $700000.0 (down 97.9% YoY), and the FY2022 annual result was $3.9 million, down 87.09% from the prior year.
- Acquisitions eased to $700000.0 in Q3 2022 per DXCM's latest filing, from $3.2 million in the prior quarter.
- Over five years, Acquisitions peaked at $31.6 million in Q3 2021 and troughed at -$1.4 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -268.10 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.30 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 700,000.00 |
| Mar 31, 2022 | 3.20 Mn |
| Dec 31, 2021 | -1.40 Mn |
| Sep 30, 2021 | 31.60 Mn |